These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9893403)

  • 1. Assessment of Adderall in ADHD.
    Diller LH
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):2. PubMed ID: 9893403
    [No Abstract]   [Full Text] [Related]  

  • 2. Adderall: the newest available option in ADHD.
    Adv Nurse Pract; 1997 Jun; 5(6):73-4. PubMed ID: 9459934
    [No Abstract]   [Full Text] [Related]  

  • 3. Adderall and other drugs for attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1994 Nov; 36(936):109-10. PubMed ID: 7968783
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis.
    Faraone SV; Biederman J
    J Atten Disord; 2002 Sep; 6(2):69-75. PubMed ID: 12142863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
    Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder.
    Grcevich S; Rowane WA; Marcellino B; Sullivan-Hurst S
    J Child Adolesc Psychopharmacol; 2001; 11(1):35-41. PubMed ID: 11322743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adderall, the atypicals, and weight gain.
    Horrigan JP; Barnhill LJ; Kohli RR
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):620. PubMed ID: 11392337
    [No Abstract]   [Full Text] [Related]  

  • 8. Inconclusive evidence puts Adderall back on the market.
    Kondro W
    CMAJ; 2005 Oct; 173(8):858. PubMed ID: 16217102
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder.
    Horrigan JP; Barnhill LJ
    J Clin Psychiatry; 2000 Jun; 61(6):414-7. PubMed ID: 10901338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug treatment of ADHD - tenuous scientific basis.
    Vogt H; Lunde C
    Tidsskr Nor Laegeforen; 2018 Jan; 138(2):. PubMed ID: 29357653
    [No Abstract]   [Full Text] [Related]  

  • 11. Adderall in the land of Oz.
    Hammerschlag C
    Caring; 2013; 32(2):55. PubMed ID: 23697076
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a reanalysis using drug-placebo and drug-drug response curve methodology.
    Faraone SV; Pliszka SR; Olvera RL; Skolnik R; Biederman J
    J Child Adolesc Psychopharmacol; 2001; 11(2):171-80. PubMed ID: 11436957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects.
    Ahmann PA; Theye FW; Berg R; Linquist AJ; Van Erem AJ; Campbell LR
    Pediatrics; 2001 Jan; 107(1):E10. PubMed ID: 11134474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis.
    Faraone SV; Biederman J; Roe C
    J Clin Psychopharmacol; 2002 Oct; 22(5):468-73. PubMed ID: 12352269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis.
    Marchetti A; Magar R; Lau H; Murphy EL; Jensen PS; Conners CK; Findling R; Wineburg E; Carotenuto I; Einarson TR; Iskedjian M
    Clin Ther; 2001 Nov; 23(11):1904-21. PubMed ID: 11768842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study.
    Faraone SV; Short EJ; Biederman J; Findling RL; Roe C; Manos MJ
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):121-9. PubMed ID: 12135536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of adult ADHD with stimulants.
    Spencer TJ
    CNS Spectr; 2007 Apr; 12(4 Suppl 6):8-11. PubMed ID: 17715564
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.
    McGough JJ; Biederman J; Greenhill LL; McCracken JT; Spencer TJ; Posner K; Wigal S; Gornbein J; Tulloch S; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):684-91. PubMed ID: 12921476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial infarction in an adolescent taking Adderall.
    Gandhi PJ; Ezeala GU; Luyen TT; Tu TC; Tran MT
    Am J Health Syst Pharm; 2005 Jul; 62(14):1494-7. PubMed ID: 15998931
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.